RxDoctor Payments Data

Tuvi Mendel, MD

Foot and Ankle Surgery · Davenport, IANPI 1033189535

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (36.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 41.5% of the total. Reporting peaked in 2022 at $9,681 and has fallen 78.2% since, to $2,108 in 2025. Among foot and ankle surgery clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,349in general payments, 2019–2025

Across 308 payments — averaging $85.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$11K
  • Wardlow Enterprises$7K
  • Arthrex$6K
  • Globus Medical$772
  • Prism Medical$503
  • Ferring Pharmaceuticals Inc.$397
  • plus $734 from 8 others

What the payments were for

  • Travel & lodging$7,96830%
  • Food & beverage$9,64637%
  • Education$8,73533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,349 in reported general payments places this provider in the 90th percentile of 112 foot and ankle surgery providers in Iowa.

See all foot and ankle surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$250,785
Medicare patients
500
Services billed
3,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin130$158
Clindamycin Hcl24$27
Meloxicam11$23

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Davenport

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →